Basel Medical (BMGL) Debt to Equity (2024 - 2025)

Basel Medical (BMGL) posted Debt to Equity of $0.93 for Q2 2025, up 143.91% sequentially from $0.38 in Q2 2024, and up 143.91% YoY from $0.38 in Q2 2024.

Basel Medical (BMGL) Debt to Equity (2024 - 2025) Analysis & Trends

Basel Medical (BMGL) has 2 years of Debt to Equity data on file, last reported at $0.93 in Q2 2025.

  • Quarterly Debt to Equity rose 143.91% year-over-year to $0.93 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $0.93 (up 143.91% YoY) and the FY2025 annual result came in at $0.9, up 133.76% from the prior year.
  • Debt to Equity grew to $0.93 in Q2 2025 per BMGL's latest filing, from $0.38 in the prior quarter.
  • The five-year high for Debt to Equity was $0.93 in Q2 2025, with the low at $0.38 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn -16.13
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 0.11
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 2.74
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn -22.31
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 0.78
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 0.06
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 0.63
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 0.05
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn 1.46
10 Basel Medical 133.19 Mn 130.39 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.93
Jun 30, 2024 0.38